Get the app
HealthcareBusiness & Enterprise

Exclusive: OpenAI has acquired Orchestra Bio

Covered by 2 sources
Read the full article
OpenAI has acquired Orchestra Bio to enhance its Rosalind AI platform for life sciences, aiming to accelerate drug development by deploying AI agents that manage research tasks. This move intensifies competition with Anthropic, which is also expanding AI applications in biotech.

Covered by 2 sources

#drug-development#openai#orchestra-bio

More in Healthcare

Healthcare6 min read

NVIDIA Cosmos3-H-Dreams: Bringing Clinical Surgery to Life Through Generative Simulation

Covered by 2 sources
Healthcare2 min read

Sierra and Stripe let AI agents take card payments during calls

Covered by 2 sources
Healthcare

Smart Hands, Human Touch: Neurotech Tightens Grip On Robotics Market

Forbes